Our easy-to-read patient fact sheet compares and contrasts sinus arrhythmia vs AFib (atrial fibrillation) symptoms.

The analyst anticipates significant revenue generation, estimating that CARDAMYST could exceed $1 billion in revenues if approved for both PSVT and AFib-RVR. Trucchio notes that the market ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered rapid ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered rapid ...

ESCAMBIA COUNTY, Fla. -- More than 12 million Americans are estimated to suffer from atrial fibrillation by 2030, according to doctors. Now, there's a new provider hoping to make treatment more ...

with proposed launch in PSVT targeted for mid-2025 - Plans to initiate Phase 3 Study in AFib-RVR in H1 2025 MONTREAL and CHARLOTTE, N.C., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Milestone ...

Eleven studies describing sinoatrial (SA) nodal, atrioventricular (AV) nodal or infra-Hisian conduction parameters in the setting of cocaine use were found. Fourteen studies and two case series ...

Upon review of this body and the described ECG findings, certain common patterns ... studies (most commonly nonsustained SVT, atrial fibrillation and sinus bradycardia). Including studies on ...